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ABSTRACT  
Locally manufactured antimicrobial susceptibility discs are becoming increasingly used in both private and 
government hospital laboratories in Nigeria. Data on the quality of these locally manufactured antimicrobial discs 
are not available. In order to provide some data, we evaluated the quality of three brands of locally manufactured 
antimicrobial susceptibility discs in common use in southeastern Nigeria. The three brands are Brodisk, Jirehdisk 
and Optudisc. The performances of these brands in agar disc diffusion assay against clinical isolates of 
Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli were compared with that of Abtek, the 
imported brand. Un-interpretable zones of inhibition defined as large zones of inhibition that merged together or 
complete wiping out of bacterial growth at the time of reading of the plate, were common with Optudisc and Jiredisk 
brands. The imported brand, Abtek, did not produce any such results. While Gentamycin on Abtek produced a 
mean diameter of zone of inhibition of 15mm, 19mm and 16mm against S. aureus, P. aeruginosa and E. coli 
respectively, the same antibiotic disc with the same stated potency on Brodisk an Jiredisk produced no zone of 
inhibition against the test bacteria. Amoxylin and Augmentin discs on Abtek produced zones of inhibition of 13mm 
and 21mm against S. aureus respectively. Amoxylin disc on Brodisk did not produce any zone of inhibition against 
the bacterial strain while Augmentin disc on Jirehdisk produced un-interpretable result. Of the three locally made 
brands, Brodisk is the only one that conformed to the international standard of not having more than eight discs per 
90mm plate. In our opinion, Brodisk can be recommended for clinical use in Nigeria with further improvement.    
The outcome of this study indicates the need for improved standardization in the production of these locally 
manufactured susceptibility discs.  
 
INTRODUCTION 
Antimicrobial susceptibility testing results provide 
guidance in the choice of antimicrobial agents in 
patient care. They also serve as a major source of 
data for surveillance of drug resistance. As such the 
accuracy of the results is of utmost priority (1, 2). 
The accuracy of results of antimicrobial 
susceptibility testing can be affected by multiple 
factors which include the media, antimicrobial 
discs or preparations, inoculum’s size, plate 
reading and incubation conditions (3) and the 
competence of the Medical Laboratory personnel 
(2). For the results to be reliable, there is need for 
careful control and standardization of the various 
steps and components of the testing procedures (3). 
 
Two groups of manual method commonly used for 
antimicrobial susceptibility testing are the Dilution 
and Disc diffusion methods. The Disc diffusion 
testing based on the Kirby-Bauer method is the 
simpler method and is therefore the most widely 
used (4). When this method is performed with strict 
adherence to the standard procedures in accordance 
to National Committee for Clinical Laboratory 
Standards (NCCLS) Method, it gives reliable 
results and can predict clinical efficacy of the 
antibiotics tested (1). One of the most critical 
components of the Disc Diffusion method is the 
quality of the antimicrobial discs. The potency and 
the accuracy of the antimicrobial content of the 
discs must be ensured. Antimicrobial discs need to 
be manufactured within strict control limits and 
handle correctly within the laboratory, otherwise, 
they cannot meet the quality and performance 
standards required. 
In the developed countries, it is believed that these 
conditions are adequately met (4). In the 
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developing countries, this may not usually be the 
case (1). In Nigeria, for instance, imported 
susceptibility discs were in common use. However, 
due to the high cost of importation, imported discs 
became expensive and scarce. Some clinical 
laboratories resorted to in-house preparation of 
their antibiotic discs. With this development, some 
private laboratories have ventured into commercial 
production of antimicrobial susceptibility discs. 
These locally manufactured discs are considerably 
cheaper than the imported discs. They are also 
more readily available. As a result, they are 
becoming widely used in both private and 
government hospitals and laboratories. There is 
little or no data on the quality of these locally 
manufactured discs. This is the major reason for 
our decision to evaluate the quality and 
performance of the three common brands of locally 
manufactured antimicrobial susceptibility discs 
used in South-eastern Nigeria in comparison with 
an imported brand. 
 
This paper presents the results of our evaluation of 
the performance characteristics of three brands of 
locally manufactured susceptibility discs. We 
highlight the need for improvement in the 
standardization of the manufacture of these local 
brands of susceptibility discs. 
 
MATERIALS AND METHODS. 
Brands of Antibiotic discs. 
Four brands of antibiotic susceptibility discs were 
used in this study. One imported brand, Abtek 
(manufactured by Abtek Biologicals Ltd, U.K) and 
three locally manufactured brands namely Optudisc 
(manufactured by Optun Laboratories, Nigeria Ltd, 
Aba), Brodisk (Bronila Diagnostic Systems, 
Enugu, Nigeria) and Jirehdisk (produced by Jireh 
Laboratories, Nigeria). Abtek multidiscs were 
purchased from C.C. Obi (Nig) Ltd, in Lagos, 
Brodisk from the manufacturer, Bronila Diagnostic 
Systems, in Enugu, Optudisc from MEDLABCOP, 
a Medical Laboratory supply group, in Port 
Harcourt, and Jirehdisk from IG Enterprises, in 
Aba. All discs were stored at 2-80C throughout the 
period of the study as recommended by the 
manufacturers. The study was done between 
August and December 2005. 
 
I l Strains 
Clinical isolates of Pseudomonas aeruginosa, 
Staphylococcus aureus and Escherichia coli were 
obtained from Microbiology Laboratory of the 
Federal Medical Centre (FMC), Umuahia, Abia 
State, Nigeria. The bacterial strains were 
subsequently maintained on Nutrient Agar slants at 
the Department of Microbiology Laboratory, 
sichael Okpara University of Agriculture, 
Umudike. Culture media used were Nutrient Agar 
(International Diagnostics Groups, Plc, Bury, 
Lancashire, U.K), and Mueller Hinton Agar (Oxoid 
Limited, Basingstoke, Hampshire, England). 
Culture media were prepared according to the 
instructions of the manufacturers.  
 
The preparation of McFarland turbidity standard 
(Tube 0.5) and the inocula of the bacterial strains 
were prepared as described by Cheesbrough (5). 
Disc Diffusion susceptibility test as originally 
described by Bauer et al (7) was carried out 
according to the procedures of the National 
Committee for Clinical Laboratory Standards 
(NCCLS) methods (6). Briefly, a sterilized wire 
loop was used to transfer 3-5 isolated colonies 
from a Nutrient agar plate into a bijou bottle 
containing about 4ml of physiological saline. The 
colonies were emulsified in the normal saline to 
obtain a homogenous suspension of the bacterial 
cells. The turbidity of the suspension was adjusted 
visually to that of 0.5 McFarland Standard by 
adding sterile physiological saline to the 
suspension.  This was used as the inoculum. A 
sterile swab stick was dipped in the standardized 
inoculum in a bijou bottle; excess fluid was 
removed from the swab by pressing it against the 
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side of the bottle. The surface of a Mueller Hinton 
agar plate previously dried in an incubator was 
streaked with the swab. The plate was left on the 
bench for about 20-30 minutes. The antimicrobial 
discs were aseptically placed on the inoculated 
plates. Each disc was gently pressed on the agar 
surface using a sterilized forceps to ensure proper 
contact. Plates were inverted within 30 minutes of 
applying the discs and incubated aerobically at 35- 
370C for 12- 18 hours. The diameter of the zone of 
inhibition around each disc was measured in 
millimetre (mm) using a plastic transparent ruler.  
RESULTS 
Three brands of locally manufactured antimicrobial 
sensitivity discs (Optudisc, Brodisk and Jirehdisk) 
were evaluated for their quality by comparing their 
performances with that of a foreign brand, Abtek 
disc, in an Agar Diffusion antibiotic susceptibility 
testing assay. Diameter of zone of inhibition 
measured in millimetres (mm) was used as a 
parameter for evaluation of the performance of the 
antibiotic discs. Table 1 presents the product 
presentation and packaging characteristics of the 
brands of antibiotic sensitivity discs evaluated in 
the study. The performance of Abtek and Brodisk 
brands of antibiotic sensitivity discs against the test 
bacteria are presented in Table 2 and Table 3 
respectively. Few antibiotics are common to both 
brands. The performances of discs of these 
antibiotics are compared in Table 4. Gentamycin 
discs on Abtek produced a mean diameter of zone 
of inhibition of 15mm, 19mm and 16 mm against 
S.aureus. P. aeruginosa and E. coli respectively. 
Gentamycin discs with the same stated antibiotic 
concentration on Brodisk produced no zone of 
inhibition against the test organisms. Similarly, 
Amoxycillin disc on Abtek produce a mean 
diameter of zone of inhibition of 13mm against S. 
aureus   but the same disc on Brodisk did not 
produce any activity. The other three antibiotics 
common to both brands namely Nitrofurantoin, 
Cloxacillin and Erythromycin produced no 
inhibition zone against the test organisms. The only 
difference being that the Abtek Nitrofurantoin disc 
had a potency of 300g while the Brodisk 
Nitrofurantoin had a potency of 2000g.  
 
Table 5 presents the results of the performance of 
the Optudisc brand and Table 6 presents that of   
Jirehdisk. Most of the discs on Optudisc brand 
produced un-interpretable zones of inhibition 
against the test bacteria. The zone of inhibition was 
regarded as un-interpretable when it was too large 
and either merged together or the whole plate was 
wiped out before the incubation period was 
reached. When this occurred in at least 2 out of 3 
plates tested, it was recorded as un-interpretable. 
This occurred most frequently with Gram Positive 
discs of Optudisc tested against S. aureus 
 
We compared the performances of discs of the 
same antibiotics common to both Abtek and 
Optudisc. The results are presented in Table 7. 
Seven antibiotics are common to Abtek and 
Jirehdisk. Comparing the performance of discs of 
these antibiotics (Table 8), Augmentin disc on 
Abtek produced a mean diameter zone of inhibition 
of 21mm against S. aureus while the disc of the 
same antibiotic on Jirehdisk produced un-
interpretable results. On the other hand while 
Gentamycin disc against Gram Positive produced a 
similar result against S. aureus for both brands, the 
discs of the antibiotic on the Gram Negative pack 
produced different results. Abtek discs produced 
zone of inhibition of 16 mm and 19 mm against 
E.coli and P. aeruginosa respectively while the 
Jirehdisk produced no zone of inhibition against 
these organisms. Ofloxacin (Tarivid) and 
Tetracycline discs produced similar results against 
P.aeruginosa (see Table 8). Out of the three local 
brands, Optudisc produced the greatest number of 
un-interpretable results followed by Jirehdisk. 
Brodisk performed closest to the Abtek indicating 
that it appeared to be the most standardized of the 
locally manufactured antibiotic sensitivity discs.
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Table 1: Product Presentation and Packaging Characteristics of the Different  





Lot No. Format and 




Total No. of 
antibiotics in each 
brand (G+ve & 
G-ve) 
Abtek UK. FC05/P 
FC06/P 
Multidisc with centre cut 
out for growth control. 
Neatly cut discs. 
8 11 
Brodisk Nigeria None Multidisc with solid 
centre, no provision for 
growth control. Fairly 
neatly cut discs.  
8 11 
Optudisc Nigeria None Mutidisc with centre cut 
out for growth control. 
Discs are rough and 
unequal in size.  
10 17 
Jirehdisk Nigeria None Mutidisc with centre cut 
out for growth control. 
Discs are rough and 




Table 2: Diameter of Zones of Inhibition (mm) Produced by Abtek Brand of Antibiotic  
Sensitivity Discs against the Test Organisms.  





   G+ve  G-ve     
Augmentin Aug 30g 30g 21 0 0 
Amoxicillin Amx 25g 25g 13 0 0 
Erythromycin Ery 5g - 0 - - 
Tetracycline Tet 10g 30g 0 13 0 
Cloxacillin Cxc 5g - 0 - - 
Gentamycin Gen 10g 10g 15 19 16 
Cotrimoxazole Cot 25g 25g 0 0 0 
Chloramphenicol Chl 30g - 20 - - 
Nitrofurantoin Nit - 300g - 0 0 
Nalidixic acid Nal - 30g - 8 0 
Ofloxacin Ofl - 30g - 31 0 
 
 
Table 3: Diameter of Zones of Inhibition (mm) produced by Brodisk  
Brand of Antibiotic Sensitivity Discs against the Test Organisms  
Antimicrobial Agent Code Stated Disc potency S. aureus P.aeruginosa E. coli  
  G+ve          G-ve    
Ampicillin AMP/PN 10mcg        25mcg 0 0 0 
Cephalexine Cx 10mcg       25mcg 0 0 0 
Cefuroxime Cxm -                 30mcg - 0 0 
Gentamycin  Gen 10mcg       10mcg 0 0 0 
Ciproxin/Ciprofloxacin Cip 5mcg         10mcg 21 33 0 
Nitrofurantoin F -               200mcg - 0 0 
Aztreonam AZM 30mcg       30mcg 0 19 *U (2of3) 
Levofloxacin Lev -                10mcg - 26 0 
Amoxicillin AM 20mcg        - 0 - - 
Cloxacilin OB  10mcg         - 0 - - 
Erythromycin E 15mcg         - 0 - - 
 
*U -    Un-interpretable diameter zone of inhibition: zone was too large and merged in with another zone.  
-    Not tested, antibiotic not on the G+ve or G-ve pack  
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Table 4: Comparison of the performance (Diameter of zones of Inhibition (mm) of Brodisk with  
Abtek discs against the test Organisms. 
 Antibiotics            Code                  Stated disc potency    
   G+ve                     G-ve  
                            Test organisms  
S. aureus                  E.coli 
  
P. aeruginosa 
 Brodisk Abtek Brodisk Abtek Brodisk Abtek Brodisk Abtek Brodisk Abtek Brodisk Abtek 
 Gentamycin  Gen/GEN  Gen  10mcg  10g  10mcg  10g 0  15  0 16  0 19 
Nitrofurantoin F Nit - - 200mcg 300g - - 0 0 0 0 
Amoxycillin AM AMX 20mcg 25g  25g 0 13 - 0 - 0 
Cloxacilin OB CXC 10mcg 5g - - 0 0 - - - - 
Erythromycin E Ery 15mcg 5g - - 0 0 - - - - 
 
Table 5: Diameter of Zone of Inhibition (mm) Produced by Optudisc Brand of Antibiotic sensitivity  
discs against the test organisms. 
Antimicrobial Agent Code Stated Disc potency Diameter of zone of inhibition (mm) 
against Test organism 
  G+ve               G-ve 
S. aureus  P.aeruginosa 
E. coli.  
Tarivid (Ofloxacillin) OFX   -                10mcg - U (2 of 3)* 13  
Peflacine PEF    -                10mcg - U (2 of 3) 0   
Ciproflox CPX 10mcg           10mcg U (3 of 3) U (2 of 3) 16   
Augmentin AU -                    30mcg - 0   0   
Gentamycin CN 10mcg            10mcg U (3 of 3)  U (2 of 3) U (2 of 3) 
Streptomycin S -                    30mcg - U(2 of 3) 18   
Ceporex CEP -                    10mcg - 0   0    
Nalidixic Acid NA  -                    30mcg - 8   0    
Septrin  
 (Co-trimoxazole) 
SxT -                    30mcg - 8   0    
Ampicillin  PN -                    30mcg - 0  0   
Norfloxacin NB -                    30mcg U (3 of 3) - - 
Lincocin LC -                    30mcg U (3 of 3) - - 
Rifampin RD 10mcg                 - U (3 of 3) - - 
Floxapen FLX 30mcg                 - U (3 of 3) - - 
Erythromycin E 30mcg                 - U (3 of 3) - - 
Chloramphenicol  CH 20mcg                 - U (3 of 3) - - 
Ampiclox  APX  30mcg                 - U (3 of 3) - - 
 
*U - Un-interpretable diameter zone of inhibition: zone was too large and merged in with another zone.  
- Not tested, antibiotic not on the G+ve or G-ve pack  
 
Table 6: Comparison of the performance (diameter of zone of inhibition (mm) of Jirehdisk discs with 
Abtek discs against the test organisms. 
  Antibiotics  Code Stated disc potency      
G+ve                     G-ve 
Test organisms  


















ek   
Augmentin  AG Aug 30mcg 30g - 30g U 21 - 0 - 0 
Septrin 
(cotrimoxazole) 
SXT COT 25mcg 25g 25mcg 25g 0 0 0 0 0 0 
Gentamycin CN Gen 10mcg 10g 10mcg 10g 17 15 0 16 0 19 
Ofloxacin 
(Tarivid) 
OFX OFL 10mcg - 10mcg 30g 22 - 0 0 0 31 
Erythromycin E Ery 5mcg 5g - - 0 0 - - - - 
Nitrofurantoin N Nit - - 200mcg 300g - - 0 0 0 0 
Tetracycline T Tet - 10g 25mcg 30g - 0 0 0 0 13 
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Table 7: Comparison of the performance (Diameter of zones of Inhibition   (mm) of Optudisc with Abtek 
discs gainst the test bacteria. 
 
*U - Un-interpretable diameter zone of inhibition: zone was too large and merged in with another zone.  
-   Not tested, antibiotic not on the G+ve or G-ve pack  
 
DISCUSSION 
The results of our evaluation of the three brands of 
locally manufactured antimicrobial susceptibility 
discs in common use in the South eastern parts of 
Nigeria indicate the need for further 
standardization of these brands of antimicrobial 
susceptibility discs.   The Three local brands 
contained different types and number of antibiotics 
on the multidisc panel. Different manufacturers 
also use different codes and in some cases different 
concentrations for the same antibiotics. 
Furthermore, while one brand includes the same 
antibiotic on the Gram Positive pack, another 
includes the same antibiotic on the Gram Negative 
Pack.  The situation reflects a state of much 
confusion, which makes it difficult to make a direct 
comparison of the performance of the different 
brands.   The situation may further be a reflection 
of lack of clear policy guidelines on antibiotic 
usage in the country or the failure of the 
manufacturers to comply with such guidelines. 
Antimicrobial agents included for susceptibility 
testing should conform to a national antibiotic 
usage policy. Furthermore, the number of discs on 
a multidisc panel for 90mm Petri dish should 
conform to International Standard such as the 
recommendation of the WHO of six or not more 
than 8 discs per such plate. In the present study, 
two of the local brands had 10 discs per plate. This 
probably contributed to the problem of un-
interpretable zones of inhibition very common to 
discs on these brands. 
 
The problem of un-interpretable zone of inhibition 
produced by some discs on the various local brands 
needs further attention. In some cases, the zones of 
inhibition were too large and either merged 
together or the whole plate was wiped out before 
the required incubation period. This occurred in at 
least 2 out of 3 plates tested before it was so 
recorded. We want to believe that this was due to 
poor standardization in the preparation of the discs. 
The discs probably contained antibiotic 
concentration above the stated potency. In 
comparison, Abtek, the imported brand did not 
produce a single case of un-interpretable result.  
Only a case of such results was observed with 
Antimicrobial 
Agents 
Code Stated disc potency      
G+ve                         G-ve 
Test organisms  





















Augumentin  AU Aug - 30g 30mcg 30g - 21 0 0 0 0 
Gentamycin CN Gen 10mcg 10g 10mcg 10g U 15 U 16 U 19 
Tarivid 
(Ofloxacillin) 
OFX Ofl - - 10mcg 30g - - 13 0 U 31 
Nalidixic acid NA Nal - - 30mcg 30g - - 0 0 8 0 
Septrin (co-
trimoxazole) 
SXT  Cot - 25g 230mcg 30g - 
 
0 0 0 8 0 
Erythromycin E Ery 30mcg 5g - - U 0 - - - - 
Chloramphenicol CH Chl 20mcg 30g - - U 20 - - - - 
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Brodisk’s Aztreonam disc against E. coli (see 
Table 3).  
The clinical implication of higher concentration of 
antibiotic beyond the required stated concentration 
in sensitivity discs is that misleading results might 
be sent to the clinicians based on the wrong results 
being produced by the discs. A bacterial strain may 
be recorded as sensitive while in actual case it is 
resistant. The wrong result could be used as the 
basis for antibiotic prescription. This will be of no 
benefit to the patient and can actually delay 
treatment with the right drug. It can further 
contribute to the problem of misuse of antibiotics 
(8) that favours the emergence of drug resistant 
strains of bacteria (9). 
 
All the three locally made brands of susceptibility 
discs evaluated in this study manifested poor 
quality and performed below expected standard in 
comparison to the imported brand. Brodisk 
performed closest to the imported brand and 
appeared to be the most standardized. With further 
improvement in quality, this brand can be 
recommended for use in Nigeria.   
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